Go to home page - PHARMAC - Pharmaceutical Management Agency
Leading Edge Medicines Management home
Patients & Consumers Health Professionals District Health Boards Pharmaceutical Suppliers

Fri May 25 2012 NZST

RSSRSS feed (help and list of feeds)

Special Authority Forms

General Practitioners and specialists can download individual Special Authority applications forms below or:

  • Click here (192 pages, 540 KB) to download all of the Special Authority forms in one document.
  • Click here for Named Patient Pharmaceutical Assessment (NPPA) forms.

Sector Services contact details

  • If you have any queries regarding the processing of paper based or declined Special Authority applications, please contact Sector Services on 0800 243 666.
  • If you are experiencing any processing errors or issues accessing the Electronic Special Authority system, please contact Sector Services on 0800 505 125 or by email.

Special Authority forms (Sort by: Therapeutic Group / Chemical Name)

Alimentary Tract and Metabolism

From page 26 of the Pharmaceutical Schedule, June 2012 (240 pages, 1314 KB)

Blood and Blood Forming Organs

From page 40 of the Pharmaceutical Schedule, June 2012 (240 pages, 1314 KB)

Cardiovascular System

From page 48 of the Pharmaceutical Schedule, June 2012 (240 pages, 1314 KB)

Dermatologicals

From page 57 of the Pharmaceutical Schedule, June 2012 (240 pages, 1314 KB)

Genito-Urinary System

From page 67 of the Pharmaceutical Schedule, June 2012 (240 pages, 1314 KB)

Hormone Preparations - Systemic Excluding Contraceptive Hormones

From page 73 of the Pharmaceutical Schedule, June 2012 (240 pages, 1314 KB)

Infections - Agents for Systemic Use

From page 80 of the Pharmaceutical Schedule, June 2012 (240 pages, 1314 KB)

Musculoskeletal System

From page 98 of the Pharmaceutical Schedule, June 2012 (240 pages, 1314 KB)

Nervous System

From page 115 of the Pharmaceutical Schedule, June 2012 (240 pages, 1314 KB)

Oncology Agents and Immunosuppressants

From page 141 of the Pharmaceutical Schedule, June 2012 (240 pages, 1314 KB)

Respiratory System and Allergies

From page 162 of the Pharmaceutical Schedule, June 2012 (240 pages, 1314 KB)

Sensory Organs

From page 169 of the Pharmaceutical Schedule, June 2012 (240 pages, 1314 KB)

Various

From page 173 of the Pharmaceutical Schedule, June 2012 (240 pages, 1314 KB)

Extemporaneously Compounded Preparations and Galenicals

From page 178 of the Pharmaceutical Schedule, June 2012 (240 pages, 1314 KB)

Special Foods

From page 182 of the Pharmaceutical Schedule, June 2012 (240 pages, 1314 KB)

Page current as of 01 Jun 2012


Linked documents

page1

Special Authority Forms, June 2012 (192 pages, 540 KB)
SPECIAL AUTHORITY FORMS June 2012 Contents Panel Approvals… 4 Alimentary Tract and Metabolism … 5 Blood and Blood Forming Organs…. 13 Cardiovascular System ….. 22 Dermatologicals …. 26 Genito-Urinary System… 30 Hormone Preparations - Systemic Excluding Contraceptive Hormones… 36 Infections…

text


page1

Pharmaceutical Schedule, June 2012 (240 pages, 1314 KB)
June 2012 Volume 19 Number 1 Editors: Kaye Wilson, Rebecca Bloor & Donna Jennings email: schedule@pharmac.govt.nz Telephone +64 4 460 4990 Facsimile +64 4 460 4995 Level 9, 40 Mercer Street PO Box 10 254 Wellington Freephone Information Line 0800…

text


page1

SA0473 - Imiglucerase (Cerezyme) therapy - entry and exit criteria (6 pages, 113 KB)
Schedule 1: Access criteria for treatment with imiglucerase (Cerezyme). Guidelines for use of imiglucerase. a) The diagnosis of symptomatic type 1 Gaucher disease must have been established by the demonstration of specific deficiency of glucocerebrosidase in leukocytes or cultured skin…

text


page1

SA0473 - Imiglucerase (Cerezyme) therapy - initial application (6 pages, 72 KB)
Initial application form for imiglucerase (Cerezyme) therapy Send completed applications to: Gaucher Panel Co-ordinator PHARMAC P O Box 10-254 WELLINGTON Fax: (04) 460 4995 Phone: (04) 460 4990 Email: gaucherpanel@pharmac.govt.nz Date of Application: _________________________________________ Patient Name: NHI number: Date of…

text


page1

SA0473 - Imiglucerase (Cerezyme) therapy - renewal application (3 pages, 75 KB)
Renewal application for imiglucerase (Cerezyme) therapy Send completed applications to: Gaucher Panel Co-ordinator PHARMAC P O Box 10-254 WELLINGTON Fax: (04) 460 4995 Phone: (04) 460 4990 Email: gaucherpanel@pharmac.govt.nz Date of Application: _________________________________________ Patient Name: NHI number: _________________________________________ Date of…

text